We are focused on development of novel biotherapeutics.
Name | Indication | Preclinical | Phase I/II (PK) | Pivotal/Phase III | FDA Approval |
Sofusa® DoseDisc™ system (anti-TNFα) | Autoimmune | ![]() |
|||
Sofusa® DoseConnect™ in Immune Oncology | Various | ![]() |
Name | Indication | Phase |
Sofusa® DoseDisc™ system (anti-TNFα) | Autoimmune | Phase I/II |
Sofusa® DoseConnect™ in Immune Oncology | Various | Preclinical |
©2018 Sofusa™. All Rights Reserved. | Terms of Use | Privacy Policy